In the second semester of 2011 the autumnal meeting of CLWG was held in Rome (November 4th) where the activity plans for 2012 has been outlined. In this occasion the resignation letter from Dr. Alberto Crotti was discussed. Dr. Crotti was the referent of the CLWG for oftalmology and his specific activity considering his competence was mainly directed toward to the relationship between leishmaniosis and ocular diseases.
Members of CLWG, expressing regret for Dr. Crotti decision accepted his resignation highlighting his professional activity that was of great help both for the scientific side and the link with SCIVAC-EV. The competence of Dr. Crotti will not covered inside the CLWG. Whether in the future, consultation about this scientific field Dr. Crotti will be contacted primarily.
Members of CLWG finalized also the discussion of the research project whose title is: “Evaluation of clinical and laboratory remission times in dogs affected by proteinuria associated with leishmanioisis that underwent to different therapeutic-management protocols”.
In the same meeting the scientific background that is based the action of domperidone (Leisguard®, Esteve) in the control of canine leishmaniosis was evaluated. The CLWG has not yet given his opinion about the efficacy of domperidone, as the scientific background supporting this drug is not yet largely demonstrated from publication of a series of papers in peer-reviewed international journals.
Finally, a draft of guidelines about prognosis and monitoring of canine leishmaniosis was discussed. In addition, the CLWG and Hill’s Pet Nutrition agreement for the next year 2012 was settled. Hill’s Pet Nutrition was the company that constantly supported the several scientific activities of CLWG.
